Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

FDMT Stock Annual Income Statement. Download in Excel

4D Molecular Therapeutics Inc logo

4D Molecular Therapeutics Inc

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

9.17
 
USD
  
0.44
  
(5.04%)
Previous close: 8.73  Open: 8.68  Bid: 9.01  Ask: 10.15
52 week range    
8.53   
   36.25
Mkt Cap: 487 M  Avg Vol (90 Days): 987,747
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Sunday 13th October 2024

Stock Rankings

37
MarketXLS Rank
60
Value
7
Technical
44
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

FDMT Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-8.82-2.57-3.32-2.58
Basic EPS total-8.82-2.57-3.32-2.58
Basic weighted shares outstanding6 M28 M32 M39 M
Depreciation1 M2 M2 M4 M
DepreciationAndAmortization1 M2 M2 M4 M
Diluted EPS total-8.82-2.57-3.32-2.58
Diluted normalized net income/share-3.32-2.58
Diluted weighted shares outstanding6 M32 M39 M
GeneralAndAdministrativeExpense17 M28 M33 M36 M
Gross operating profit14 M18 M3 M21 M
Income before tax-57 M-71 M-107 M-101 M
Interest income152000.0137000.03 M12 M
MiscOtherSpecialCharges-181000.0-121000.0-35000.0-181000.0
Net income from total operations-57 M-71 M-107 M-101 M
NetIncomeCommonStockholders-57 M-71 M-107 M-101 M
NetIncomeContinuousOperations-57 M-71 M-107 M-101 M
NetNonOperatingInterestIncomeExpense152000.0137000.03 M12 M
Normalized income-80 M
Operating income-57 M-71 M-110 M-113 M
Operating income before depreciation (EBITDA)-55 M-68 M-106 M-107 M
OperatingExpense70 M89 M113 M134 M
Other income net181000.0121000.035000.0-181000.0
OtherGandA17 M28 M33 M36 M
OtherOperatingExpenses-2 M-2 M-3 M-4 M
Research & development expense53 M61 M80 M97 M
ResearchExpense53 M61 M80 M97 M
Selling Gen & administrative expense17 M28 M33 M36 M
Total Income available for interest expense (EBIT)-57 M-71 M-110 M-113 M
Total common shares outstanding27 M32 M33 M50 M
Total net income-57 M-71 M-107 M-101 M
Total ordinary shares52 M52 M52 M52 M
Total revenues14 M18 M3 M21 M
TotalExpenses70 M89 M113 M134 M
TotalRevenue14 M18 M3 M21 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University